Targeting survivin to overcome docetaxel resistance in prostate cancer

被引：0
|
作者：
Peery, Robert C. [1 ]
机构：
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4396
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4396
引用
收藏
页数：1
相关论文
共 50 条
  • [11] MicroRNA-195 regulates docetaxel resistance by targeting clusterin in prostate cancer
    Ma, Xiaokun
    Zou, Liyuan
    Li, Xing
    Chen, Zhanhong
    Lin, Qu
    Wu, Xiangyuan
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 99 : 445 - 450
  • [12] Targeting hypoxia-induced immune suppression to overcome immunotherapy resistance in prostate cancer
    Jayaprakash, Priyamvada
    Ai, Midan
    Liu, Arthur
    Budhani, Pratha
    Bartkowiak, Todd
    Sheng, Jie
    Ager, Casey
    Nicholas, Courtney
    Jaiswal, Ashvin
    Sun, Yanqiu
    Shah, Krishna
    Balasubramanyam, Sadhana
    Li, Nan
    Wang, Guocan
    Ning, Jing
    Zal, Anna
    Zal, Tomasz
    Curran, Michael
    CANCER RESEARCH, 2019, 79 (13)
  • [13] Overcoming Docetaxel Resistance in Prostate Cancer by Targeting FAK Phosphorylation, and Its Mode of Action
    Lee, B. Y.
    Hochgraefe, F.
    Lin, H. M.
    Castillo, L.
    Raftery, M.
    Horvath, L. G.
    Daly, R. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 48 - 49
  • [14] PROSTATE CANCER Fitting to overcome enzalutamide resistance
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2016, 13 (10) : 564 - +
  • [15] Tumor metabolism and Docetaxel resistance in prostate cancer
    Ippolito, L.
    Taddei, M. L.
    Marini, A.
    Chiarugi, P.
    FEBS JOURNAL, 2014, 281 : 612 - 612
  • [16] Molecular mechanisms of docetaxel resistance in prostate cancer
    Sekino, Yohei
    Teishima, Jun
    CANCER DRUG RESISTANCE, 2020, 3 (04) : 676 - 685
  • [17] Tumor metabolism and docetaxel resistance in prostate cancer
    Taddei, M.
    Marini, A.
    Ippolito, L.
    Morandi, A.
    Giannoni, E.
    Chiarugi, P.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S65 - S65
  • [18] TARGETING TUMOR OXIDATIVE METABOLISM TO OVERCOME HYPOXIA-INDUCED IMMUNOTHERAPY RESISTANCE IN PROSTATE CANCER
    Jayaprakash, Priyamvada
    Curran, Michael
    Morrow, Brittany
    Marszalek, Joseph
    Bhanu, Krithikaa Rajkumar
    Rice, Meghan
    Gay, Jason
    Vellano, Christopher
    Cowen, Benjamin
    Welsch, Dean
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A868 - A868
  • [19] Targeting mTOR Complex 2 in Castration-Resistant Prostate Cancer with Acquired Docetaxel Resistance
    Huang, Yujie
    Zhai, You
    Wu, Meijia
    Chang, Chengdong
    Luo, Jindan
    Hong, Dongsheng
    Zhao, Qingwei
    Dai, Yao
    Liu, Jian
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 3817 - 3828
  • [20] Ritonavir reverses resistance to docetaxel and cabazitaxel in prostate cancer cells with acquired resistance to docetaxel
    Putten, Eric van der
    Wosikowski, Katja
    Beijnen, Jos H.
    Imre, Gabor
    Freund, Colin R.
    CANCER DRUG RESISTANCE, 2024, 7
12345